Antiviral pharmaceutical composition for treating lymphocytes

Details Antiviral pharmaceutical composition for treating lymphocytes Antiviral pharmaceutical composition for treating lymphocytes

1992-10-07

1994-06-14

Cintins, Marianne M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

5142235, A61K 3154

Patent

active

053210247

ABSTRACT:
The present invention provides a pharmaceutical composition containing 3,4-dihydro-1-phenyl-1-thio -1,2,4-benzothiadiazine 1-oxide useful for protecting lymphocytes.

REFERENCES:
patent: 4100280 (1978-07-01), Dillard et al.
patent: 4171361 (1979-10-01), Dillard et al.
Abstract 23,434 for FR-M-4 279 (J. Vernin) Published Derwent Abstract Aug. 16, 1966.
Abstract 92-176013/22 for Wo-A-9 208 462 Boehringer Mannheim GmbH Derwent Abstract Published May 21, 1992.
Abstract 09345W-06 for DE-A-2 335 147 (Beiersdorf AG) Derwent Abstract Published Jan. 27, 1977.
Abstract 07856Y/05 for DE-A-2 530 792 (Godecke AG) Derwent Abstract Published Jan. 30, 1975.
Weislow, O. S., et al., J. Natl. Cancer Inst., vol. 81, No. 8, Apr. 19, 1989.

Affiliated with

Also associated with

Rating

Antiviral pharmaceutical composition for treating lymphocytes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiviral pharmaceutical composition for treating lymphocytes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral pharmaceutical composition for treating lymphocytes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1249382